Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum Therma Bright Inc V.THRM

Alternate Symbol(s):  TBRIF

Therma Bright Inc. is a developer and partner in a range of diagnostic and medical device technologies. It focuses on providing consumers and medical professionals with solutions that address medical and healthcare challenges. It is involved in developing, acquiring, manufacturing, and marketing proprietary healthcare and medical devices for the consumer and institutional marketplace. Its... see more

TSXV:THRM - Post Discussion

Therma Bright Inc > Just wondering
View:
Post by 13X2413 on Feb 15, 2022 12:12pm

Just wondering

We've waited for months for news about the effectiveness of the tests. Finally, this morning it looks like we were on the way. 

I guess, judging by the action on the price of the stock, this news wasn't good enough. 

What the heck is it going to take to get this off of it's a**?!

Comment by YoungBaklava on Feb 15, 2022 12:17pm
Just getting approval means nothing unless you actually make money with it, so to start seeing major financial results in stock movement, thrm must strike a large deal with a country/business willing to utilize their tests. Yes ther than that the company is profit less rn, price of stock is only governed by potential so far. But the test does look promising compared to others aswell as a huge ...more  
Comment by YoungBaklava on Feb 15, 2022 12:18pm
Yes ther= Other*****
Comment by spygate on Feb 15, 2022 12:25pm
FDA final submission news and then FDA approval is what will move this
Comment by Smokey1958 on Feb 15, 2022 12:38pm
Some of those shorting the stock were going to get caught with their pants down ....thus the risk of investing this way. They were never going to disappear quietly. The bulk of the shares moved before 11:00am as buyers and sellers were dueling. Now the penny flippers and shorters have moved to drive the price lower which is seen in multiple trades of volumes of 500. This afternoon will be ...more  
Comment by moonball32 on Feb 15, 2022 2:11pm
Agreed, next 6 weeks takes us to end of 1st quarter. I would expect Rob put NR to keep clients and shareholders at bay. One would think that the application to FDA is only days away, they would have had everything ready to go except for the results, now that is done, my guess is Thursday for another update.
Comment by Canadian0620144 on Feb 15, 2022 2:23pm
My guess will take more than having a test that works. The next major news will be FDA approval in next few weeks.  I think will happen soon next Friday but just a guess.  Volume last month Jan 16th-Feb 15th 10ml shares all at average 0.3745. High 0.435 Low 0.325. Nice volume today 2.1ml averaging 0.401. Can't blame the traders who booked a +10% profit. Currently buying under 0 ...more  
Comment by spygate on Feb 15, 2022 3:09pm
and dont discount the feds decsion today on not requiring negative PCR testing prior to coming home. Now if we could ever get to a point that the ramdom testing that is being done at the airport could ustylize these saliva tests then we would be in business. Also positive that we arent in the pCR testing business as it looks like thos are going to be overtaken by Antigen testing...quicker, cheaper ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities